|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-5-9
|
|
pubmed:abstractText |
Case-control and prospective studies indicate that an elevated plasma homocysteine level is a powerful risk factor for atherosclerotic vascular diseases. Certain medications can induce hyperhomocystinemia, such as methotrexate, trimethoprim and anti-epileptic drugs. There are few reports indicating an interaction between lipid-lowering drugs (cholestyramine and niacin) and homocysteine. Recently, an interaction was shown between fenofibrate and benzafibrates (a fibric acid derivative) and homocysteine plasma levels.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1565-1088
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
243-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11344833-Adult,
pubmed-meshheading:11344833-Bezafibrate,
pubmed-meshheading:11344833-Clofibric Acid,
pubmed-meshheading:11344833-Dietary Fats,
pubmed-meshheading:11344833-Female,
pubmed-meshheading:11344833-Fibric Acids,
pubmed-meshheading:11344833-Homocysteine,
pubmed-meshheading:11344833-Humans,
pubmed-meshheading:11344833-Hyperlipidemias,
pubmed-meshheading:11344833-Hypolipidemic Agents,
pubmed-meshheading:11344833-Male,
pubmed-meshheading:11344833-Middle Aged,
pubmed-meshheading:11344833-Triglycerides
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Homocysteine elevation with fibrates: is it a class effect?
|
|
pubmed:affiliation |
Institute of Lipid and Atherosclerosis Research, Sheba Medical Center, Tel-Hashomer, Israel. dharats@post.tau.ac.il
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
